Skip to main content

Find Clinical Trials

Home
Conditions
Urogenital Neoplasms

Clinical trial condition

Urogenital Neoplasms

Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.

11,806 public trials 2,510 recruiting studies

Refine in advanced search Browse all conditions

Urogenital Neoplasms trial results

Active, Not Recruiting

Atezolizumab + Guadecitabine in Patients With Checkpoint Inhibitor Refractory or Resistant Urothelial Carcinoma

NCT03179943

Conditions: Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +17 more
Locations: USC Norris Hospital and Clinics Los Angeles, California, United States

Johns Hopkins University School of Medicine Baltimore, Maryland, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

Endocrine Disrupting Chemical Exposure and Testicular Cancer

NCT04848545

Conditions: Endocrine Gland Neoplasms, Endocrine System Diseases, Genital Diseases, +11 more
Locations: Department of Growth and Reproduction, Rigshospitalet Copenhagen, Denmark

EDMaRC, Rigshospitalet secton 5064 Copenhagen, Denmark

View Trial Details

Active, Not Recruiting

Study of Tumour Focused Radiotherapy for Bladder Cancer

NCT02447549

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Riverina Cancer Care Centre Wagga Wagga, New South Wales, Australia

Princess Alexandra Hospital Brisbane, Queensland, Australia

Townsville General Hospital Douglas, Queensland, Australia

Radiation Oncology Mater Centre QLD South Brisbane, Queensland, Australia

View all 49 locations

View Trial Details

Active, Not Recruiting

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical Cancer

NCT02490748

Conditions: Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: Not specified

View Trial Details

Active, Not Recruiting

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma

NCT02487693

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Not specified

View Trial Details

Active, Not Recruiting

CIK in Treating Patients With Bladder Cancer

NCT02489890

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +8 more
Locations: Not specified

View Trial Details